Lazarus: Forte’s 500 Picograms Of Meloxicam Would Not Have Triggered ‘Positive’ Under HISA’s ADMC Program

HISA CEO Lisa Lazarus made an interesting comment regarding the disqualification of juvenile champion Forte in an interview with the Thoroughbred Daily News on Friday, the day before the 2023 Preakness Stakes.

Lazarus referenced a report in bloodhorse.com in which Steven Barker, a chemist, LSU professor, and expert witness for Forte's connections, indicated that 500 picograms (or 0.5 nanograms) of meloxicam was found in the colt's system after the running of the 2022 Grade 1 Hopeful Stakes. Lazarus told the TDN that amount would not have triggered a positive under HISA's Anti-Doping and Medication Control Program rules, which launched Monday, May 22.

“I'm not going to talk about Forte specifically, but what I will tell you is that HISA's screening limits from meloxicam track the International Federation of Horseracing Authorities' screening limits,” Lazarus told TDN. “Therefore, our screening limit is one nanogram per milliliter in blood and 10 nanograms per milliliter in hydrolyzed urine. If what has been reported–and I haven't verified this–but if that positive was [indeed] 500 picograms, that would be below our screening limit and would not ever be notified as a positive under HISA.”

Trainer Todd Pletcher has also stated that he believes the meloxicam positive is a result of contamination and that Forte had never been prescribed or administered the drug.

Lazarus addressed HISA's contamination policy as well: “HISA has an atypical findings policy with 27 substances listed, and if [one of those] substances are detected in a horse's system, it goes through a special process to determine whether or not it's contamination. That's reviewed by the scientific committee. If the committee determines that it is contamination, then it never even rises to a violation.

“There's another provision in our rules called contaminated product. In that situation, if it's not subject to the atypical findings policy, and it's above the screening limit, there would still be disqualification. But the trainer could argue that it was a contaminated product or there was contamination, and they have the opportunity to have their sanction reduced to zero if they can convince the arbitration panel that it was contamination.”

Just days after Forte was scratched as the favorite on the morning of the Kentucky Derby, the New York Times broke the news that the colt had a drug positive still pending from his juvenile season. The Times' Joe Drape reported that two sources close to the situation say the positive is from a post-race test taken after Forte's win in the Grade 1 Hopeful Stakes at Saratoga in September. Drape's sources indicated the substance in question was “used to relieve pain and reduce inflammation” but was not specifically named.

Adjudication of the positive dragged on; a spokesperson for the New York State Gaming Commission told Drape the delays were “sought by the trainer's counsel,” but Forte's connections later disputed that assertion.

Meanwhile, after his win in the Hopeful, Forte went on to capture the G1 Breeders' Futurity at Keeneland, followed by the G1 Breeders' Cup Juvenile, earning him the 2022 Eclipse Award for Champion 2-Year-Old Colt.

Although he had been projected as the morning-line favorite in the G1 Kentucky Derby, Forte was scratched the morning of the race by Kentucky state veterinarians after his connections said he had been battling a foot bruise for several days. He was unable to race in the Preakness Stakes, because a veterinary scratch triggers an automatic entry to the vet's list for 14 days and requires a workout and blood test for removal from the list.

Forte is now reported to be targeting the G1 Belmont Stakes.

Read more at the Thoroughbred Daily News.

The post Lazarus: Forte’s 500 Picograms Of Meloxicam Would Not Have Triggered ‘Positive’ Under HISA’s ADMC Program appeared first on Horse Racing News | Paulick Report.

Source of original post

Three Lingering NY Drug Positives as Testing Transfers to HISA

On the day that Thoroughbred drug testing nationwide got transferred to the control of the Horse Racing Integrity and Safety Act (HISA) Authority, Robert Williams, the executive director for the New York State Gaming Commission (NYSGC), disclosed during that board's monthly meeting that three outstanding Thoroughbred drug positives remain unadjudicated by the commission and are still lingering at various stages in the regulatory process.

That disclosure is not only timely because of the HISA Authority's May 22 implementation of the Anti-Doping and Medication Control program. Monday's news of the three additional unadjudicated tests was important because those unresolved cases were made public nearly two weeks after a brouhaha erupted about 2-year-old champion Forte (Violence) having failed a post-win NYSGC drug test at Saratoga Race Course on Sept. 5, 2022.

The finding of meloxicam, a non-steroidal anti-inflammatory drug, in Forte's system wasn't the entirety of that controversy. A more concerning aspect of the issue was that Forte's positive was kept from the public for more than nine months, and wasn't revealed until May 9, 2023, when the New York Times first broke the story, citing as sources “two people who are familiar with the matter but are not authorized to speak about it.”

On May 11, the NYSGC formally announced Forte's disqualification from the Hopeful while imposing fine of $1,000 and 10-day suspension upon trainer Todd Pletcher. Those penalties have been appealed, and both the NYSGC and Pletcher's legal team have bickered back and forth, with each side publicly blaming the other for causing extended delays in the process that involved split sample testing and the scheduling of a stewards' hearing.

Williams described the three other currently unadjudicated drug tests as being in the pipeline “at either qualified, accredited, independent laboratories or awaiting determination through a meeting of the stewards.”

Commissioner John Crotty asked Williams, “Do you have a timeline on resolving them?”

Williams was quick to answer: “I don't know the specifics of any of those cases,” he said.

Crotty responded, “Okay…” before NYSGC chairman Brian O'Dwyer interjected.

“I suspect, Mr. Crotty, given the situation, that we will be very, very diligent in terms of making sure that those things are adjudicated much more promptly,” said O'Dwyer, ending that discussion.

Williams noted that the outstanding Thoroughbred drug positives were current through May 19, but that the NYSGC will retain control over any sampling taken through May 21.

The commission will also maintain its testing obligation in harness racing, “as HISA has yet to address that industry,” Williams said. He added that there are two outstanding Standardbred drug tests awaiting adjudication.

Williams said that the Forte controversy has sparked NYSGC changes to the way it will handle any adjudications that remain under the board's control.

“Changes to the split sample procedure have been instituted to reduce the ability of an affected party to game the system,” Williams said.

“Absent extraordinary circumstances, from now on a trainer advised of a positive drug violation will be afforded no more than two weeks to identify and make arrangements for the split sample to be tested,” Williams said.

“Additionally, upon notification of the split sample result being returned, the stewards' meeting must be conducted within three weeks. If a trainer cannot appear within three weeks' time, they will be deemed to have constructively waived their appearance before the stewards, and the matter will proceed,” Williams said.

After Williams finished giving his report, O'Dwyer said that he wanted to express “my thanks and the thanks of the commission members for setting the record straight in regards to the Pletcher matter.”

O'Dwyer continued: “I think it's very important that, and was quite unfortunate, some of the reporting that came out, [and] the board and commission and our staff needs to be commended for the way that they handled it. I understand there were some time differences. But they did everything they could to give Mr. Pletcher considerable due process, and I'm glad that [Williams] was able to correct the record in that regard.”

Pletcher's attorney, Karen Murphy, had given a contrasting synopsis of the delay to TDN back on May 11.

“One point I want to address up front is that the gaming commission has stated now two or three times that we somehow delayed the process,” Murphy said at that time. “That's a little bit shocking to me because it's false. I don't like government regulators to make false statements. [From] day one, we were on this. This delay is wholly on the gaming commission. It's because they weren't prepared to proceed with the case in a professional, orderly manner.”

The post Three Lingering NY Drug Positives as Testing Transfers to HISA appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Mendelssohn Filly Brings $800k from Speedway at Midlantic Sale

A filly by Mendelssohn (hip 245) brought a final bid of $800,000 from Peter Fluor of Speedway Stables during Monday's first session of the Fasig-Tipton Midlantic May 2-Year-Olds in Training Sale. The gray, who is out of stakes-placed Lady Hansen (Hansen), was consigned by Paul Sharp. Sharp purchased the filly as part of his pinhooking partnership with Liz Crow for $125,000 at last year's Keeneland September sale.

It was the second big purchase of the afternoon for Speedway, which also went to $500,000 to acquire a colt by Not This Time (hip 198) from the Pick View consignment.

The post Mendelssohn Filly Brings $800k from Speedway at Midlantic Sale appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

New Owner, Trainer Bonus Program at Belmont Stakes Racing Festival

The New York Racing Association, Inc. (NYRA) will offer a number of unique incentives for owners and trainers at the Belmont Stakes Racing Festival, slated for Thursday, June 8 through Saturday, June 10, at Belmont Park which will be highlighted by the 155th running of the GI Belmont S., the final jewel of the Triple Crown.

The event will encompass 16 stakes races worth a combined $7.65 million while the June 10 Belmont Stakes card will feature nine graded events, including three Breeders' Cup qualifying races as part of the “Win and You're In” series. During the three-day Belmont Stakes Racing Festival, horses placed fourth through last in stakes races and horses placed second through last in non-stake races, will receive a starter bonus as set forth here for each eligible starter as part of the “Starter Bonus Program.”

Additionally, trainers whose horses start in any race during the Festival (all races on Thursday, June 8th; Friday, June 9th; or Saturday, June 10th) that are not stabled at a NYRA track (Belmont Park and Saratoga Race Course), will receive a shipping bonus of $1,000 to be credited to the owner's account towards shipping expenses. Requirements for both bonuses include that the horse must be declared an official starter. Horses that are placed on a poor performance and/or veterinarian list will not be eligible for the bonus.

For additional information on the 2023 Belmont Stakes Racing Festival and details on hospitality offerings, ticket packages and pricing, visit the official page of the Belmont Stakes.

The post New Owner, Trainer Bonus Program at Belmont Stakes Racing Festival appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Verified by MonsterInsights